title: Minimal disease activity for rheumatoid arthritis: a preliminary definition.
abstract: Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. The threshold for MDA is between high disease activity and remission and, by definition, anyone in remission will also be in MDA. True remission is still rare in RA; in addition, the American College of Rheumatology definition is difficult to apply in the context of trials. Participants at OMERACT 6 in 2002 agreed on a conceptual definition of minimal disease activity (MDA): "that state of disease activity deemed a useful target of treatment by both the patient and the physician, given current treatment possibilities and limitations." To prepare for a preliminary operational definition of MDA for use in clinical trials, we asked rheumatologists to assess 60 patient profiles describing real RA patients seen in routine clinical practice. Based on their responses, several candidate definitions for MDA were designed and discussed at the OMERACT 7 in 2004. Feedback from participants and additional on-site analyses in a cross-sectional database allowed the formulation of 2 preliminary, equivalent definitions of MDA: one based on the Disease Activity Score 28 (DAS28) index, and one based on meeting cutpoints in 5 out the 7 WHO/ILAR core set measures. Researchers applying these definitions first need to choose whether to use the DAS28 or the core set definition, because although each selects a similar proportion in a population, these are not always the same patients. In both MDA definitions, an initial decision node places all patients in MDA who have a tender joint count of 0 and a swollen joint count of 0, and an erythrocyte sedimentation rate (ESR) no greater than 10 mm. If this condition is not met: * The DAS28 definition places patients in MDA when DAS28 < or = 2.85; * The core set definition places patients in MDA when they meet 5 of 7 criteria: (1) Pain (0-10) < or = 2; (2) Swollen joint count (0-28) < or = 1; (3) Tender joint count (0-28) < or = 1; (4) Health Assessment Questionnaire (HAQ, 0-3) < or = 0.5; (5) Physician global assessment of disease activity (0-10) < or = 1.5; (6) Patient global assessment of disease activity (0-10) < or = 2; (7) ESR < or = 20. This set of 2 definitions gained approval of 73% of the attendees. These (and other) definitions will now be subject to further validation in other databases.
authors.affiliation: Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: George A
authors.initials: GA
authors.lastname: Wells
authors.forename: Maarten
authors.initials: M
authors.lastname: Boers
authors.forename: Beverley
authors.initials: B
authors.lastname: Shea
authors.forename: Peter M
authors.initials: PM
authors.lastname: Brooks
authors.forename: Lee S
authors.initials: LS
authors.lastname: Simon
authors.forename: C Vibeke
authors.initials: CV
authors.lastname: Strand
authors.forename: Daniel
authors.initials: D
authors.lastname: Aletaha
authors.forename: Jennifer J
authors.initials: JJ
authors.lastname: Anderson
authors.forename: Claire
authors.initials: C
authors.lastname: Bombardier
authors.forename: Maxime
authors.initials: M
authors.lastname: Dougados
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
authors.forename: David T
authors.initials: DT
authors.lastname: Felson
authors.forename: Jaap
authors.initials: J
authors.lastname: Fransen
authors.forename: Dan E
authors.initials: DE
authors.lastname: Furst
authors.forename: Johanna M W
authors.initials: JM
authors.lastname: Hazes
authors.forename: Kent R
authors.initials: KR
authors.lastname: Johnson
authors.forename: John R
authors.initials: JR
authors.lastname: Kirwan
authors.forename: Robert B M
authors.initials: RB
authors.lastname: Landewé
authors.forename: Marissa N D
authors.initials: MN
authors.lastname: Lassere
authors.forename: Kaleb
authors.initials: K
authors.lastname: Michaud
authors.forename: Maria
authors.initials: M
authors.lastname: Suarez-Almazor
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Silman
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
authors.forename: Desiree M F M
authors.initials: DM
authors.lastname: Van der Heijde
authors.forename: Piet L C M
authors.initials: PL
authors.lastname: van Riel
authors.forename: Fred
authors.initials: F
authors.lastname: Wolfe
authors.forename: Peter S
authors.initials: PS
authors.lastname: Tugwell
mesh_terms: D001172:Arthritis, Rheumatoid / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology*; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods*; D012372:ROC Curve; D012720:Severity of Illness Index; D016896:Treatment Outcome